Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.

Author

  • Åke Lernmark
  • H E Larsson

Department/s

  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Diabetes and Celiac Unit
  • Paediatric Endocrinology

Publishing year

2011

Language

English

Pages

132-135

Publication/Series

Journal of Internal Medicine

Volume

270

Document type

Journal article (letter)

Publisher

Wiley-Blackwell

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes and Celiac Unit
  • Paediatric Endocrinology

ISBN/ISSN/Other

  • ISSN: 1365-2796